Close X
Sunday, September 22, 2024
ADVT 
International

Washington asks India about alleged assassination plot against US-Canadian activist

Darpan News Desk The Canadian Press, 22 Nov, 2023 11:19 AM
  • Washington asks India about alleged assassination plot against US-Canadian activist

The U.S. government says it asked Indian authorities about allegations of a foiled assassination plot targeting a U.S.-Canadian citizen and it expects anyone deemed responsible to be "held accountable."

National Security Council spokeswoman Adrienne Watson says in a statement the U.S. government is "treating the issue with utmost seriousness" and raised it with the "senior-most" levels of India's government.

She was responding to a report in the Financial Times alleging U.S. authorities thwarted a plan to assassinate Sikhs for Justice general counsel Gurpatwant Singh Pannun on American soil, and raised concerns that India's government was involved.

Pannun, a dual citizen, is an organizer of a series of Sikh separatist votes in Canada and the United States.

Watson says in a statement that Indian officials expressed "surprise and concern" and told the Americans that such activities were not their policy.

India's High Commission in Ottawa did not immediately return messages seeking comment.

Pannun was in British Columbia as recently as late October, when a Sikh gurdwara hosted the second round of a non-binding vote on the establishment of Khalistan — an independent Sikh state within India.

The gurdwara's leader, Hardeep Singh Nijjar, was shot dead outside the temple in June, and Canadian Prime Minister Justin Trudeau said in September there were "credible allegations" linking the killing to India's government.

 

MORE International ARTICLES

FDA approves first COVID-19 drug: antiviral remdesivir

FDA approves first COVID-19 drug: antiviral remdesivir
The drug, which California-based Gilead Sciences Inc. is calling Veklury, cut the time to recovery by five days — from 15 days to 10 on average — in a large study led by the U.S. National Institutes of Health.

FDA approves first COVID-19 drug: antiviral remdesivir

Here we go again: Trump, Biden reprise debate duel

Here we go again: Trump, Biden reprise debate duel
Instead, they're bracing for another show of vintage Trump, one in which he'll seek to be heard even in spite of his muted microphone.

Here we go again: Trump, Biden reprise debate duel

Getting ready for the gong show: Trump v. Biden II

Getting ready for the gong show: Trump v. Biden II
It's the sequel to last month's debate horror show between Donald Trump and Joe Biden, an invective-laced 90 minutes that laid bare the depths to which political discourse can sink in an American election year.

Getting ready for the gong show: Trump v. Biden II

US overdose deaths appear to rise amid coronavirus pandemic

US overdose deaths appear to rise amid coronavirus pandemic
Davidson lost his job. He started staying home alone in his apartment near Georgetown, Kentucky — depressed and yearning for his recovery support group that had stopped gathering in person, said his cousin Melanie Wyatt.

US overdose deaths appear to rise amid coronavirus pandemic

Pfizer: Mid-November earliest it can seek virus vaccine OK

Pfizer: Mid-November earliest it can seek virus vaccine OK
Another leading U.S. contender, Moderna Inc., previously announced the earliest it could seek authorization of its own vaccine would be Nov. 25.

Pfizer: Mid-November earliest it can seek virus vaccine OK

UN: Europe's pandemic restrictions are absolutely necessary

UN: Europe's pandemic restrictions are absolutely necessary
In a meda briefing on Thursday, Dr. Hans Kluge warned that even more drastic steps might be needed in such “unprecedented times.”

UN: Europe's pandemic restrictions are absolutely necessary